This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
A Adachi , N Shimizu , Y Oomura & M Kobashi (1984) Convergence of hepatoportal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract. Neurosci Lett 46, 215–218.
B Ahrén (2004) Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice. Am J Physiol Regul Integr Comp Physiol 286, R269–R272.
B Ahrén , H Larsson & JJ Holst (1997) Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82, 473–478.
B Ahrén , J Holst , H Martensson & B Balkan (2000) Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice. Eur J Pharmacol 404, 239–245.
E Alvarez , I Roncero , JA Chowen , B Thorens & E Blazquez (1996) Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem 66, 920–927.
HJ Balks , JJ Holst , A von zur Muhlen , G Brabant (1997) Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J Clin Endocrinol Metab 82, 786–790.
G Bell , R Sanchez-Pescador , P Laybourn & R Najarian (1983) Exon duplication and divergence in the human preproglucagon gene. Nature 304, 368–371.
HR Berthoud , A Niijima , JF Sauter & B Jeanrenaud (1983) Evidence for a role of the gastric, coeliac and hepatic branches in vagally stimulated insulin secretion in the rat. J Auton Nerv Syst 7, 97–110.
DW Biggers , SR Myers , D Neal , R Stinson , NB Cooper , JB Jaspan , PE Williams , AD Cherrington & RT Frizzell (1989) Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes 38, 7–16.
E Blazquez , E Alvarez , M Navarro , I Roncero , F Rodriguez-Fonseca , JA Chowen & JA Zueco (1998) Glucagon-like peptide-1 (7–36) amide as a novel neuropeptide. Mol Neurobiol 18, 157–173.
JC Brown (1971) A gastric inhibitory peptide. I. The amino acid composition and the tryptic peptides. Can J Biochem 49, 255–261.
PL Brubaker (1991) Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128, 3175–3182.
A Buchan , J Polak , C Capella , E Solcia & A Pearse (1978) Electron immunocytochemical evidence for the K-cell. Localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 56, 37–44.
R Burcelin & B Thorens (2001) Evidence that extrapancreatic GLUT2-dependent glucose sensors control glucagon secretion. Diabetes 50, 1282–1289.
R Burcelin , E Rolland , W Dolci , S Germain , V Carrel & B Thorens (1999) Encapsulated, genetically engineered cells, secreting glucagon-like peptide-1 for the treatment of non-insulin-dependent diabetes mellitus. Ann NY Acad Sci 875, 277–285.
R Burcelin , W Dolci & B Thorens (2000a) Glucose sensing by the hepatoportal sensor is GLUT-2 dependent; in vivo analysis in GLUT-2 null mice. Diabetes 49, 1643–1648.
R Burcelin , W Dolci & B Thorens (2000b) Portal glucose infusion in the mouse induces hypoglycemia. Evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49, 1635–1642.
R Burcelin , A Da Costa , D Drucker , B Thorens (2001) Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 50, 1720–1728.
MM Byrne & B Goke (1996) Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use. Diabet Med 13, 854–860.
RV Campos , YC Lee & DJ Drucker (1994) Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134, 2156–2164.
W Creutzfeldt (1979) The incretin concept today. Diabetologia 16, 75–85.
WO Creutzfeldt , N Kleine , B Willms , C Orskov , JJ Holst & MA Nauck (1996) Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7–36) amide in type I diabetic patients. Diabetes Care 19, 580–586.
P Cryer (1981) Glucose counterregulation in man. Diabetes 30, 261–264.
A Damholt , H Kofod & A Buchan (1999) Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine. Cell Tissue Res 298, 287–293.
CF Deacon , AH Johnsen & JJ Holst (1995a) Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80, 952–957.
CF Deacon , MA Nauck , M Toft-Nielsen , L Pridal , B Willms & JJ Holst (1995b) Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes 44, 1126–1131.
J Donahey , G Van Dijk , S Woods & R Seeley (1998) Intraventricular GLP-1 reduced short but not long term food intake or body weight in lean and obese rats. Brain Res 779, 75–83.
DJ Drucker (1990) Glucagon and the glucagon-like peptides. Pancreas 5, 484–488.
DJ Drucker (1998) Glucagon-like peptides. Diabetes 47, 159–169.
M During , L Cao & D Zuzga (2003) Glucagon like peptide 1 receptor is involved in learning and neuroprotection. Nat Med 9, 1173–1179.
R Ebert & W Creutzfeldt (1982) Influence of gastric inhibitory polypeptide antiserum on glucose induced insulin secretion in rats. Endocrinology 111, 1601–1606.
R Ebert , H Unger & W Creutzfeldt (1983) Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption. Diabetologia 24, 449–454.
HC Fehmann , B Goke , V Weber , R Goke , ME Trautmann , G Richter & R Arnold (1990) Interaction of glucagon-like peptide-1 (7–36) amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas. Pancreas 5, 361–365.
HC Fehmann , R Goke , B Goke , R Bachle , B Wagner & R Arnold (1991) Priming effect of glucagon-like peptide-1 (7–36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Biochim Biophys Acta 1091, 356–363.
T Fridolf & B Ahren (1993) Effects of glucagon like peptide-1(7–36) amide on the cytoplasmic Ca(2+)-concentration in rat islet cells. Mol Cell Endocrinol 96, 85–90.
RT Frizzell , EM Jones , SN Davis , DW Biggers , SR Myers , CC Connolly , DW Neal , JB Jaspan & AD Cherrington (1993) Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes 42, 1253–1261.
N Fukase , H Takahashi , H Manaka , M Igarashi , K Yamatani , M Daimon , K Sugiyama , M Tominaga & H Sasaki (1992) Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion. Diabetes Res Clin Pract 15, 187–195.
N Fukase , M Igarashi , H Takahashi , H Manaka , K Yamatani , M Daimon , M Tominaga & H Sasaki (1993) Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabet Med 10, 44–49.
M Furuse , M Matsumoto , J Okumura , K Sugahara & S Hasegawa (1997) Intracerebroventricular injection of mammalian and chicken glucagon-like peptide-1 inhibits food intake of the neonatal chick. Brain Res 755, 167–169.
B Gallwitz , M Witt , UR Folsch , W Creutzfeldt & WE Schmidt (1993) Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7–36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells. J Mol Endocrinol 10, 259–268.
A Gardemann , H Strulik & K Jungermann (1986) A portal–arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused rat liver. FEBS Lett 202, 255–259.
J Gerich , P Cryer & R Rizza (1990) Hormonal mechanisms in acute glucose counterregulation: the relative role of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. Metabolism 29, 1164–1175.
R Goke , B Wagner , HC Fehmann & B Goke (1993) Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7–36) amide on the rat pancreas. Res Exp Med 193, 97–103.
R Goke , PJ Larsen , JD Mikkelsen & SP Sheikh (1995) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7, 2294–2300.
AP Goldstone , I Morgan , JG Mercer , DG Morgan , KM Moar , MA Ghatei & SR Bloom (2000) Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA. Biochem Biophys Res Commun 269, 331–335.
DM Hargrove , NA Nardone , LM Persson , JC Parker & RW Stevenson (1995) Glucose-dependent action of glucagon-like peptide-1 (7–37) in vivo during short- or long-term administration. Metabolism 44, 1231–1237.
C Herrmann , R Goke , G Richter , HC Fehmann , R Arnold & B Goke (1995) Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56, 117–126.
C Herrmann-Rinke , A Voge , M Hess & B Goke (1995) Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides. J Endocrinol 147, 25–31.
AL Hevener , RN Bergman & CM Donovan (1997) Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 46, 1521–1525.
AL Hevener , RN Bergman & CM Donovan (2000) Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 49, 8–12.
JJ Holst (1977) Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity. Diabetologia 13, 159–169.
JJ Holst (1994) Glucagon like peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 107, 1848–1855.
JJ Holst (1997) Enteroglucagon. Annu Rev Physiol 59, 257–271.
JJ Holst , C Orskov , OV Nielsen & TW Schwartz (1987) Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 211, 169–174.
GGt Holz , WM Kuhtreiber & JF Habener (1993) Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7–37). Nature 361, 362–365.
T Ikeda , H Ochi , I Ohtani , K Fujiyama , T Hoshino , Y Tanaka , T Takeuchi & H Mashiba (1993) Possible role of the adrenergic mechanism in gastric inhibitory polypeptide- and glucagon-like peptide-1 (7–36) amide-induced insulin release in the rat. Metabolism 42, 209–213.
C Juhl , O Schmitz , S Pincu , J Holdt , J Veldhuis & N Porksen (2000) Short-term treatment with GLP-1 increases pulsatile insulin secretion in type II diabetes with no effect on orderliness. Diabetologia 43, 583–588.
SM Kanse , B Kreymann , MA Ghatei & SR Bloom (1988) Identification and characterization of glucagon-like peptide-1 7–36 amide-binding sites in the rat brain and lung. FEBS Lett 241, 209–212.
JM Knapper , A Heath , JM Fletcher , LM Morgan & V Marks (1995) GIP and GLP-1(7–36)amide secretion in response to intraduodenal infusions of nutrients in pigs. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 111, 445–450.
NN Kok , HS Taper & NM Delzenne (1998b) Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats. J Appl Toxicol 18, 47–53.
F Kolligs , HC Fehmann , R Goke & B Goke (1995) Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9–39) amide. Diabetes 44, 16–19.
R Komatsu , T Matsuyama & M Namba (1989) Glucagonostatic and insulinotropic action of glucagon like peptide-1-(7–36)-amide. Diabetes 38, 902–905.
B Kreymann , MA Ghatei , P Burnet , G Williams , S Kanse , AR Diani & SR Bloom (1989) Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus. Brain Res 502, 325–331.
MP Mattson , T Perry & N Greig (2003) Learning from the gut. Nat Med 9, 1113–1114.
K Miyawaki , Y Yamada & H Yano (1999) Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96, 14843–14847.
S Mojsov , GC Weir & JF Habener (1987) Insulinotropin: glucagon-like peptide I (7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79, 616–619.
A Moody , L Thim & I Valverde (1984) The isolation and sequencing of human gastric inhibitory polypeptide (GIP). FEBS Lett 172, 142–148.
B Moore , E Edie & J Abram (1906) On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem J 1, 28–38.
MC Moore & AD Cherrington (1996) The nerves, the liver, and the route of feeding: an integrated response to nutrient delivery. Nutrition 12, 282–284.
D Nathan , E Schreiber , H Fogel , S Mojsov & J Habener (1991) Insulinotropic action of glucagon like peptide-1-(7–37) in diabetic and non diabetic subjects. Diabetes Care 15, 270–275.
MA Nauck (1998) Glucagon like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol 35, 117–129.
MA Nauck , E Bartels , C Orskov , R Ebert & W Creutzfeldt (1993a) Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7–36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 76, 912–917.
MA Nauck , MM Heimesaat , C Orskov , JJ Holst , R Ebert & W Creutzfeldt (1993b) Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91, 301–307.
MA Nauck , N Kleine , C Orskov , JJ Holst , B Willms & W Creutzfeldt (1993c) Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7–36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36, 741–744.
A Niijima (1969) Afferent impulse discharges from glucoreceptors in the liver of the guinea pig. Ann NY Acad Sci 157, 690–700.
A Niijima (1985) Blood glucose levels modulate efferent activity in the vagal supply to the rat liver. J Physiol 364, 105–112.
Y Oomura , T Ono , H Ooyama & MJ Wayner (1969) Glucose and osmosensitive neurones of the rat hypothalamus. Nature 222, 282–284.
Y Oomura , H Ooyama , M Sugimori , T Nakamura & Y Yamada (1974) Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus. Nature 247, 284–286.
C Orskov , JJ Holst & OV Nielsen (1988) Effect of truncated glucagon-like peptide-1, proglucagon-(78–107) amide, on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology 123, 2009–2013.
C Orskov , L Rabenhoj , A Wettergren , H Kofod & JJ Holst (1994) Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43, 535–539.
C Orskov , A Wettergren & JJ Holst (1996) Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Scand J Gastroenterol 31, 665–670.
MJ Pagliassotti , SR Myers , MC Moore , DW Neal & AD Cherrington (1991) Magnitude of negative arterial–portal glucose gradient alters net hepatic glucose balance in conscious dogs. Diabetes 40, 1659–1668.
MJ Pagliassotti , LC Holste , MC Moore , DW Neal & AD Cherrington (1996) Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J Clin Invest 97, 81–91.
M Perley & D Kpnis (1967) Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 46, 1954–1962.
P Plaisancie , V Dumoulin , JA Chayvialle & JC Cuber (1995) Luminal glucagon-like peptide-1(7–36) amide-releasing factors in the isolated vascularly perfused rat colon. J Endocrinol 145, 521–526.
TM Plant & AR Durrant (1997) Circulating leptin does not appear to provide a signal for triggering the initiation of puberty in the male rhesus monkey ( Macaca mulatta ). Endocrinology 138, 4505–4508.
C Qualmann , MA Nauck , JJ Holst , C Orskov & W Creutzfeldt (1995) Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7–36 amide] in the fasting state in healthy subjects. Acta Diabetol 32, 13–16.
RA Reimer & MI McBurney (1996) Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology 137, 3948–3956.
U Ritzel , A Fromme , M Ottleben , U Leonhardt & G Ramadori (1997) Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetol 34, 18–21.
R Rizza , P Cryer & J Gerich (1979) Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation: effects of somatostatin and combined alpha and beta adrenergic blockade on plasma glucose recovery and glucose flux rates following insulin-induced hypoglycemia. J Clin Invest 64, 62–71.
J Roberge , K Gronau & P Brubaker (1996) Gastrin-releasing peptide is a novel mediator of proximal nutrient-induced proglucagon-derived peptide secretion from the distal gut. Endocrinology 137, 2383–2388.
AS Rocca & PL Brubaker (1995) Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures. Endocrinology 136, 5593–5599.
AS Rocca & PL Brubaker (1999) Role of vagus nerve in mediating proximal nutrient induced glucagon like peptide-1 secretion. Endocrinology 140, 1687–1694.
de Rodriquez , F Fonseca , M Navarro & E Alvarez (2000) Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 49, 709–717.
Y Rouille , G Westermark , SK Martin & DF Steiner (1994) Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc Natl Acad Sci USA 91, 3242–3246.
Y Rouille , S Martin & DF Steiner (1995) Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide. J Biol Chem 270, 26488–26496.
J Schirra , M Katschinski , C Weidmann , T Schafer , U Wank , R Arnold & B Goke (1996) Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97, 92–103.
LA Scrocchi , TJ Brown , N MaClusky , PL Brubaker , AB Auerbach , AL Joyner & DJ Drucker (1996) Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2, 1254–1258.
K Shima , M Hirota & C Ohboshi (1988) Effect of glucagon-like peptide-1 on insulin secretion. Regul Pept 22, 245–252.
I Shimizu , M Hirota , C Ohboshi & K Shima (1987) Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. Endocrinology 121, 1076–1082.
N Shimizu , Y Oomura , D Novin , CV Grijalva & PH Cooper (1983) Functional correlations between lateral hypothalamic glucose-sensitive neurons and hepatic portal glucose-sensitive units in rat. Brain Res 265, 49–54.
F Stumpel & K Jungermann (1997) Sensing by intrahepatic muscarinic nerves of a portal–arterial glucose concentration gradient as a signal for insulin-dependent glucose uptake in the perfused rat liver. FEBS Lett 406, 119–122.
J Takeda , Y Seino & K Tanaka (1987) Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor. Proc Natl Acad Sci USA 84, 7005–7008.
Y Tanizawa , AC Riggs , SC Elbein , A Whelan , H Donis-Keller & MA Permutt (1994) Human glucagon-like peptide-1 receptor gene in NIDDM. Identification and use of simple sequence repeat polymorphisms in genetic analysis. Diabetes 43, 752–757.
B Thorens & G Waeber (1993) Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42, 1219–1225.
B Thorens , A Porret , L Buhler , SP Deng , P Morel & C Widmann (1993) Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9–39) an antagonist of the receptor. Diabetes 42, 1678–1682.
MD Turton , D O'Shea & I Gunn (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69–72.
LO Uttenthal , A Toledano & E Blazquez (1992) Autoradiographic localization of receptors for glucagon-like peptide-1 (7–36) amide in rat brain. Neuropeptides 21, 143–146.
AA Vaag , JJ Holst , A Volund , HB Beck-Nielsen (1996) Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM) – evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins. Eur J Endocrinol 135, 425–432.
G van Dijk & TE Thiele (1999) Glucagon-like peptide-1 (7–36) amide: a central regulator of satiety and interoceptive stress. Neuropeptides 33, 406–414.
B van Eyll , B Lankat-Buttgereit , HP Bode , R Goke & B Goke (1994) Signal transduction of the GLP-1-receptor cloned from a human insulinoma. FEBS Lett 348, 7–13.
A Volz , R Goke , B Lankat-Buttgereit , HC Fehmann , HP Bode & B Goke (1995) Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. FEBS Lett 373, 23–29.
Z Wang , RM Wang , AA Owji , DM Smith , MA Ghatei & SR Bloom (1995) Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest 95, 417–421.
Y Wei & S Mojsov (1995) Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 358, 219–224.
A Wettergren , M Wojdemann , S Meisner , F Stadil & JJ Holst (1997) The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7–36 amide on gastric acid secretion in humans depends on an intact vagal innervation. Gut 40, 597–601.
B Willms , J Werner , JJ Holst , C Orskov , W Creutzfeldt & MA Nauck (1996) Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7–36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab 81, 327–332.
S Yoshimoto , M Hirota , C Ohboshi & K Shima (1989) Identification of glucagon-like peptide-1(7–36) amide in rat brain. Ann Clin Biochem 26, 169–171.
AA Young , BR Gedulin & TJ Rink (1996) Dose–responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7–36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. Metabolism 45, 1–3.
WS Zawalich & KC Zawalich (1996) Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol. Metabolism 45, 273–278.
WS Zawalich , KC Zawalich & H Rasmussen (1993) Influence of glucagon-like peptide-1 on beta cell responsiveness. Regul Pept 44, 277–283.
Y Zhang , JT Cook , AT Hattersley , R Firth , PJ Saker , M Warren-Perry , M Stoffel & RC Turner (1994) Non-linkage of the glucagon-like peptide 1 receptor gene with maturity onset diabetes of the young. Diabetologia 37, 721–724.